Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates
SHANGHAI, Aug. 26, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2026 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2026, the company’s…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
